April 24, 2020 / 6:12 PM / a month ago

BRIEF-FDA Gives Updates On Adverse Event Reports And Postmarket Activities Related To Bayer's Essure

April 24 (Reuters) - FDA:

* FDA PROVIDES UPDATES ON ADVERSE EVENT REPORTS AND POSTMARKET ACTIVITIES ASSOCIATED WITH ESSURE

* FDA- BAYER IS REQUIRED TO START PROVIDING REPORTABLE ADVERSE EVENTS TO FDA IN JULY 2020 RELATED TO ESSURE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below